cPLA₂ Antibodies

Santa Cruz Biotechnology features a diverse variety of cPLA₂ monoclonal antibodies for various research applications. cPLA₂ Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytosolic phospholipase A₂ (cPLA₂) plays a crucial role in the release of arachidonic acid from membrane phospholipids, which is a precursor for the synthesis of bioactive lipids involved in inflammation and cell signaling. cPLA₂ is essential for various physiological processes, including immune response and cellular signaling pathways. Understanding cPLA₂ function is vital for elucidating its role in diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. Research into cPLA₂ continues to reveal new insights about its involvement in cellular processes and disease mechanisms. Investigating cPLA₂ activity helps advance our understanding of inflammatory responses and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for cPLA₂ support researchers worldwide in advancing scientific knowledge and developing potential therapeutic strategies.